FDAnews Announces -- Labeling for Prescription Drugs, Biologics and Combination Products:Complying with FDA's Most Recent IFU Guidance Webinar, Oct. 29, 2019
FALLS CHURCH, Va., Oct. 15, 2019 /PRNewswire-PRWeb/ -- Labeling for Prescription Drugs, Biologics and Combination Products: Complying with FDA's Most Recent IFU Guidance **An FDAnews Webinar** Tuesday, October 29, 2019, 1:30-3:00 p.m. EDT https://www.fdanews.com/labelpredrug
What implications does the recent Instructions for Use (IFU) guidance have on new drug applications and biologics license applications?
How will the current content and format for IFUs need to be modified?
Alan G. Minsk, Esq. ? a partner and leader of the Food & Drug Practice Team of Arnall Golden Gregory LLP ? will clarify the new guidance and explain how to comply with it.
During this webinar, attendees will discuss:
Why FDA issued the draft guidance and its importance to regulatory, quality and compliance specialists, including the content and format concerns of FDA in general and details necessary for safe and effective use
What kind of language IFUs should be written in to be patient friendly
What the guidance recommends in terms of voice, commands and sentences
Examples of sample labeling that covers all elements of an IFU from dosage and usage to storage and disposal
What kinds of recommendations FDA makes in terms of design and layout, such as the use of easy-to-read fonts, sequential numbering and white space
Some practical considerations on patient labeling, from a business perspective
If one is at all unclear how to implement this guidance and change IFUs to include what the FDA considers to be "clear, concise information that is easily understood," one must attend this webinar. NDAs and BLAs depend on it.
Interested in registering multiple sites? Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.
Webinar Details: Labeling for Prescription Drugs, Biologics and Combination Products: Complying with FDA's Most Recent IFU Guidance **An FDAnews Webinar** Tuesday, October 29, 2019, 1:30-3:00 p.m. EDT https://www.fdanews.com/labelpredrug?hittrk=19O15VOCUS [https://www.fdanews.com/labelpredrug __title__ Patient Prescription Labeling]
About FDAnews: FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations
Children's Minnesota is thrilled to announce the 32nd annual Star Gala raised $2.3 million to benefit the nonprofit pediatric health system's neuroscience program. Star Gala is regarded as one of the biggest nights of the year for the Twin Cities...
The European Wellness Biomedical Group (EWBG), in collaboration with the European Wellness Academy (EWA), the Baden Research Lab, and Heidelberg University, has announced substantial advances in Down Syndrome research, revealing new neuroanatomical...
Proprietary E3 ligase platform to enable protein stabilisation "at source", thereby restoring the body's sophisticated natural disease suppression processes Platform scales the assessment of E3 ligase targets while addressing the historic challenges...
SK chemicals (CEO Ahn Jae-hyun), Dongsung Chemical (Co-CEOs Baek Jin-woo and Lee Man-woo), and BYN Black Yak (Chairman Kang Tae-sun, hereinafter Black Yak) announced on the 18th that they've developed sustainable footwear materials using the...
First quarter
Sales of SEK 841 (854) million, a flat growth in local currencies and a decrease of 2% in SEK.Sales per region, in local currencies was +19% in APAC, -2% in EMEA and -14% in Americas.Sales per business area, in local currencies was...